Navigation Links
ACR, SBI on cancer study: More breast cancer screening needed in younger women
Date:9/8/2013

A new analysis published online Sept. 9 in Cancer confirms the need for greater use of annual mammography in women ages 40-49 as recommended by the American Cancer Society, American Congress of Obstetricians and Gynecologists (ACOG), American College of Radiology and Society of Breast Imaging for all women 40 and older. It also confirms that, even with new therapeutics and protocols for treating breast cancer, regular mammography screening is still the best way to significantly reduce breast cancer deaths.

The study, which involved 7,301 patients, found that 71 percent of confirmed breast cancer deaths occurred in the 20 percent of the study population that did not receive regular mammograms. The majority of those who died from breast cancer never had a mammogram prior to diagnosis. If treatment were the primary survival factor, deaths would not have been so prevalent among the non-screened group.

Moreover, 50 percent of the breast cancer deaths occurred in women under the age of 50, while only 13 percent were in women ages 70 or older. For women who died of breast cancer, the median age at diagnosis was 49; for those dying of any other cause, the median age at diagnosis was 72. This suggests that women under 50 are a primary group in which greater screening compliance would provide the greatest benefit.

"These findings should quiet those who argue that women age 40-49 do not need regular mammography screening. In fact, these women need annual screening as do all women 40 and older. This is the message physicians should be promoting," said Barbara S. Monsees, MD, FACR, chair of the American College of Radiology Breast Imaging Commission. "Breast cancer treatment has come a long way, but, as this study demonstrates, these advances have not negated the value of, or the need for early detection. This is especially true for younger women, who tend to have faster growing tumors."

Unlike previous studies on the value of mammography that have shown varying benefits, these findings provide more definitive information through a technique called "failure analysis" which looks backwards from death to discover correlations at diagnosis. Harvard Medical School Professor of Surgery (emeritus) Blake Cady, MD, and his colleagues followed cases of invasive breast cancer diagnosed between 1990 and 1999 at Partners HealthCare hospitals through 2007, analyzing demographics, mammography use, surgical and pathology reports and recurrence and death dates to discover correlations.

"This study should effectively end confusion over when, and particularly if, women need to begin screening. Every year, breast cancer takes too many of our mothers, wives, sisters and friends. While these findings cannot bring back those already lost, they clearly demonstrate that mammography saves lives, and many more deaths can be avoided through regular screening," said Murray Rebner, MD, FACR, president of the Society of Breast Imaging.

While breast cancer mortality has been on steady decline (about 2 percent per year) in the last two decades, the majority of deaths that are still occurring are in women who do not receive regular mammograms. With more prevalent screening, especially in younger women, the study suggests that breast cancer mortality could decrease to much less than 10 percent overall in the next ten years, and perhaps to as low as 5 percent overall by 2030.


'/>"/>

Contact: Shawn Farley
PR@acr.org
703-648-8936
American College of Radiology
Source:Eurekalert

Related medicine news :

1. Actos Bladder Cancer Lawsuits Move Forward, with Issuance of New Order in Federal Actos Litigation, Bernstein Liebhard LLP Reports
2. Drinking Before First Pregnancy Can Lead To Breast Cancer And Disease
3. CEO of Award-Winning SEO Services Company, 180Fusion, Scott Cohen Elected to Emcee 2013 Prostate Cancer Dinner Gala
4. Co-sponsors highlight important research to be presented at the 2013 Breast Cancer Symposium
5. Bone growth factor may increase benign tumors but not malignant cancer
6. Injury Lawyers Release New Informational Graphic about the Alleged Link Between Victoza and Cancer
7. Molecular marker predicts patients most likely to benefit longest from 2 popular cancer drugs
8. Mount Sinai Receives NIH Grant to Increase the Engagement of African Americans in Colorectal Cancer Screening
9. Key research from the 2013 Breast Cancer Symposium highlights new insights
10. Kidney Cancer Association Earns Coveted 4-Star Rating from Charity Navigator
11. Actos Lawsuit News: Bernstein Liebhard LLP Notes Start of Second Actos Bladder Cancer Trial in Maryland State Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... Manhattan New york (PRWEB) , ... April 28, ... ... is pleased to announce that Aditya Patel M.D. has joined the revolutionary endoscopic ... fellowship training and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... their work assisting the Brooke Grove Foundation implement a Microsoft Dynamics GP solution ... Solutions, a leading ERP expert that specializes in long-term care, Brooke Grove now ...
(Date:4/28/2017)... ... ... Christie Medical Holdings, Inc. , with its market-leading vein finder ... a leader in infusion therapy and pain management. , Intravenous (IV) therapy plays ... patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals ...
(Date:4/27/2017)... Minnesota (PRWEB) , ... April 27, 2017 , ... ... and her husband Dan Gasby the 2017 Public Leadership in Neurology Award (PLINA). ... Woodruff, retired professional athlete Tedy Bruschi, Vice President Walter Mondale, actor Michael J. ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... PUNE, India , April 19, 2017 ... Type and Application, Forecast to 2022 report has covered and ... provides statistics and information on market size, shares and growth ... with major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and ...
Breaking Medicine Technology: